Pivotal BioVenture Partners China, an investment platform of Hong Kong conglomerate Nan Fung Group, has led a $16.5 million seed round for Sino-US cancer drug developer Oncologie.
Other investors in the round included Nan Fung Life Sciences, a division of Nan Fung that operates across Greater China and the US. China Merchant Bank Investments and Volcanics Ventures also participated....
SeaLink Capital Partners has led a INR2 billion ($29 million) investment in Indian maternal and pediatric hospital chain Surya Children’s Medicare, providing an exit for OrbiMed Advisors.
Japan's governance reforms have given activist investors more leverage over underperforming companies. PE firms are well positioned to offer solutions to these targets in the form of carve-outs, privatizations, or partnerships
Chinese B2B pharmaceutical trading and education platform Yaoshibang has received RMB420 million ($65 million) in Series C funding across two tranches.
A group of VCs including China Growth Capital have agreed to invest $16 million in Ono, a China-based company that claims to be the creator of the first decentralized social network.